Hunan Gaoxin Industrial Investment directors review Tianchuang Precision, Hechuang Jizhi operations in Q3 visit

Hunan Pharmaceutical Development PE Fund managers visited portfolio companies Tianchuang Precision, Hechuang Jizhi, Hunan Pharmaceutical Group on Sept. 17-18, 2026. Site inspections covered Tianchuang Precision’s production lines, Hechuang Jizhi’s new plant construction. Reviews focused on Jan.-Aug. target progress, project execution, next-stage strategy. External directors urged sharper strategic positioning, faster innovation, tighter cost control, stronger risk management. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hunan Pharmaceutical Development Private Equity Fund Management Co Ltd published the original content used to generate this news brief on September 20, 2026, and is solely responsible for the information contained therein. (C)